// App-Quantinova.ai

893 : The Role of D-Dimer for Optimal Thromboprophylaxis Strategy in Patients with COVID-19

Researchers

Presenter

  • Lantarima Bhoopat

Principal Investigators

  • Anastasia Martynova

  • April Choi

  • Pattharawin Pattharanitima

  • Semi Han

  • Senxi Du

  • Ibrahim Syed

  • Catherine Chan

  • Caitlin O'Neill

  • Esther Oh

  • Casey L. O'Connell

Medical Centers

  • Hematology, Department of Internal Medicine, Thammasat University, Patumthani, Thailand

  • University of Southern California, Jane Anne Nohl Division of Hematology, Los Angeles, CA

  • Internal Medicine, University of Southern California, Los Angeles/US

  • Hematology, Department of Internal Medicine, Thammasat University, Patumthani, Thailand

  • Department of Nuclear Medicine, University of California, Los Angeles, CA

  • University of Southern California Keck School of Medicine, Los Angeles, CA

  • Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA

  • UCLA Care Center, Los Angeles, CA

  • University of Southern California, Jane Anne Nohl Division of Hematology, Los Angeles, CA

  • LAC+USC Medical Center, Los Angles, CA

  • Division of Hematology, Keck School of Medicine, University of Southern California, Los Angeles, CA

Locations

  • Thailand

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Venous thrombosis

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • Heparin

  • Enoxaparin

  • Enoxaparin sodium

  • Heparin

Outcome

  • N/A


Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A